220 related articles for article (PubMed ID: 34748870)
1. Targeting bone microenvironments for treatment and early detection of cancer bone metastatic niches.
Yang H; Yu Z; Ji S; Huo Q; Yan J; Gao Y; Niu Y; Xu M; Liu Y
J Control Release; 2022 Jan; 341():443-456. PubMed ID: 34748870
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of tumor cells in the bone microenvironment: Mechanisms and therapeutic targets for bone metastasis of prostate or breast cancer.
Futakuchi M; Fukamachi K; Suzui M
Adv Drug Deliv Rev; 2016 Apr; 99(Pt B):206-211. PubMed ID: 26656603
[TBL] [Abstract][Full Text] [Related]
3. Bone Metastasis of Breast Cancer.
Tahara RK; Brewer TM; Theriault RL; Ueno NT
Adv Exp Med Biol; 2019; 1152():105-129. PubMed ID: 31456182
[TBL] [Abstract][Full Text] [Related]
4. Tasquinimod inhibits prostate cancer growth in bone through alterations in the bone microenvironment.
Magnusson LU; Hagberg Thulin M; Plas P; Olsson A; Damber JE; Welén K
Prostate; 2016 Mar; 76(4):383-93. PubMed ID: 26660725
[TBL] [Abstract][Full Text] [Related]
5. Hypoxic Microenvironment and Metastatic Bone Disease.
Hiraga T
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30423905
[TBL] [Abstract][Full Text] [Related]
6. The Endosteal Niche in Breast Cancer Bone Metastasis.
Haider MT; Smit DJ; Taipaleenmäki H
Front Oncol; 2020; 10():335. PubMed ID: 32232008
[TBL] [Abstract][Full Text] [Related]
7. Basic and clinical associations between bone and cancer.
He F; Matsumoto Y
Immunol Med; 2020 Sep; 43(3):103-106. PubMed ID: 32301686
[TBL] [Abstract][Full Text] [Related]
8. Modifying the osteoblastic niche with zoledronic acid in vivo-potential implications for breast cancer bone metastasis.
Haider MT; Holen I; Dear TN; Hunter K; Brown HK
Bone; 2014 Sep; 66(100):240-50. PubMed ID: 24971713
[TBL] [Abstract][Full Text] [Related]
9. [Encounter of cancer cells with bone. The bone microenvironment and cancer metastases].
Hata K; Nakanishi M; Morita Y; Yoneda T
Clin Calcium; 2011 Mar; 21(3):349-56. PubMed ID: 21358055
[TBL] [Abstract][Full Text] [Related]
10. Bone metastasis: mechanisms, therapies, and biomarkers.
Clézardin P; Coleman R; Puppo M; Ottewell P; Bonnelye E; Paycha F; Confavreux CB; Holen I
Physiol Rev; 2021 Jul; 101(3):797-855. PubMed ID: 33356915
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow niches in the regulation of bone metastasis.
Chen F; Han Y; Kang Y
Br J Cancer; 2021 Jun; 124(12):1912-1920. PubMed ID: 33758331
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis and treatment of prostate cancer bone metastases: targeting the lethal phenotype.
Loberg RD; Logothetis CJ; Keller ET; Pienta KJ
J Clin Oncol; 2005 Nov; 23(32):8232-41. PubMed ID: 16278478
[TBL] [Abstract][Full Text] [Related]
13. [Encounter of cancer cells with bone. Development of bone metastasis-specific targeting therapy].
Hayashi S; Hanamura T
Clin Calcium; 2011 Mar; 21(3):389-96. PubMed ID: 21358060
[TBL] [Abstract][Full Text] [Related]
14. Dissecting the role of bone marrow stromal cells on bone metastases.
Buenrostro D; Park SI; Sterling JA
Biomed Res Int; 2014; 2014():875305. PubMed ID: 25054153
[TBL] [Abstract][Full Text] [Related]
15. A multi-targeted approach to treating bone metastases.
Camacho DF; Pienta KJ
Cancer Metastasis Rev; 2014 Sep; 33(2-3):545-53. PubMed ID: 24390423
[TBL] [Abstract][Full Text] [Related]
16. Targeting the Hepatocyte Growth Factor and c-Met Signaling Axis in Bone Metastases.
Whang YM; Jung SP; Kim MK; Chang IH; Park SI
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30658428
[TBL] [Abstract][Full Text] [Related]
17. Targeted Agents in Preclinical and Early Clinical Development for the Treatment of Cancer Bone Metastases.
Hiraga T
Expert Opin Investig Drugs; 2016; 25(3):319-34. PubMed ID: 26778342
[TBL] [Abstract][Full Text] [Related]
18. Examining the metastatic niche: targeting the microenvironment.
Guise T
Semin Oncol; 2010 Oct; 37 Suppl 2():S2-14. PubMed ID: 21111245
[TBL] [Abstract][Full Text] [Related]
19. Intervention with the Bone-Associated Tumor Vicious Cycle through Dual-Protein Therapeutics for Treatment of Skeletal-Related Events and Bone Metastases.
Niu Y; Yang H; Yu Z; Gao C; Ji S; Yan J; Han L; Huo Q; Xu M; Liu Y
ACS Nano; 2022 Feb; 16(2):2209-2223. PubMed ID: 35077154
[TBL] [Abstract][Full Text] [Related]
20. New therapeutic targets for cancer bone metastasis.
Krzeszinski JY; Wan Y
Trends Pharmacol Sci; 2015 Jun; 36(6):360-73. PubMed ID: 25962679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
